Michael P. Hedrick

2.8k total citations
35 papers, 2.2k citations indexed

About

Michael P. Hedrick is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Michael P. Hedrick has authored 35 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Michael P. Hedrick's work include Biochemical and Molecular Research (6 papers), Cannabis and Cannabinoid Research (5 papers) and Cancer therapeutics and mechanisms (5 papers). Michael P. Hedrick is often cited by papers focused on Biochemical and Molecular Research (6 papers), Cannabis and Cannabinoid Research (5 papers) and Cancer therapeutics and mechanisms (5 papers). Michael P. Hedrick collaborates with scholars based in United States, Italy and Germany. Michael P. Hedrick's co-authors include Dale L. Boger, Brian E. Fink, Winston C. Tse, S.R. Brunette, Hiroshi Miyauchi, Robert Fecik, Qing Jin, Benjamin F. Cravatt, D. R. Soenen and Inkyu Hwang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Michael P. Hedrick

34 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Hedrick United States	23	1.3k	689	540	389	324	35	2.2k
Michael S. Malamas United States	27	1.5k 1.2×	1.2k 1.7×	610 1.1×	295 0.8×	161 0.5×	71	3.3k
Donmienne Leung United States	18	1.2k 1.0×	545 0.8×	995 1.8×	332 0.9×	411 1.3×	26	2.9k
Mojgan Aghazadeh Tabrizi Italy	37	1.8k 1.4×	1.9k 2.8×	430 0.8×	291 0.7×	469 1.4×	104	4.0k
Zoran Ranković United States	23	2.3k 1.8×	1.4k 2.0×	763 1.4×	366 0.9×	666 2.1×	67	4.0k
Rita Scarpelli Italy	25	1.0k 0.8×	600 0.9×	502 0.9×	519 1.3×	129 0.4×	48	2.0k
Annette M. Doherty United States	34	1.7k 1.3×	1.2k 1.7×	226 0.4×	451 1.2×	222 0.7×	97	3.5k
Murray J. B. Brown United Kingdom	28	2.2k 1.8×	879 1.3×	585 1.1×	229 0.6×	151 0.5×	41	3.2k
Douglas S. Johnson United States	34	2.1k 1.7×	1.6k 2.4×	1.3k 2.5×	359 0.9×	430 1.3×	74	4.3k
Khaled A. M. Abouzid Egypt	36	1.5k 1.2×	2.4k 3.4×	475 0.9×	505 1.3×	167 0.5×	158	3.8k
Takayuki Doi Japan	39	1.9k 1.5×	3.4k 4.9×	894 1.7×	277 0.7×	277 0.9×	262	5.3k

Countries citing papers authored by Michael P. Hedrick

Since Specialization

Citations

This map shows the geographic impact of Michael P. Hedrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Hedrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Hedrick more than expected).

Fields of papers citing papers by Michael P. Hedrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Hedrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Hedrick. The network helps show where Michael P. Hedrick may publish in the future.

Co-authorship network of co-authors of Michael P. Hedrick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Hedrick. A scholar is included among the top collaborators of Michael P. Hedrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Hedrick. Michael P. Hedrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stanford, Stephanie M., Michael A. Diaz, Robert Ardecky, et al.. (2021). Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase. Journal of Medicinal Chemistry. 64(9). 5645–5653. 13 indexed citations

Slosky, Lauren M., Yushi Bai, Krisztián Tóth, et al.. (2020). β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors. Cell. 181(6). 1364–1379.e14. 94 indexed citations

Pinkerton, Anthony B., Satyamaheshwar Peddibhotla, Lauren M. Slosky, et al.. (2019). Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators. Journal of Medicinal Chemistry. 62(17). 8357–8363. 32 indexed citations

Sen, Triparna, Carminia Maria Della Corte, Snezana Milutinovic, et al.. (2019). Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC. Journal of Thoracic Oncology. 14(12). 2152–2163. 91 indexed citations

Roy, Sudeshna, Justina Šileikytė, Marco Schiavone, et al.. (2015). Discovery, Synthesis, and Optimization of Diarylisoxazole‐3‐carboxamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore. ChemMedChem. 10(10). 1655–1671. 38 indexed citations

Nicola, George, Michael R. Berthold, Michael P. Hedrick, & Michael K. Gilson. (2015). Connecting proteins with drug-like compounds: Open source drug discovery workflows with BindingDB and KNIME. Database. 2015. bav087–bav087. 19 indexed citations

Hershberger, Paul, Michael P. Hedrick, Satyamaheshwar Peddibhotla, et al.. (2013). Imidazole-derived agonists for the neurotensin 1 receptor. Bioorganic & Medicinal Chemistry Letters. 24(1). 262–267. 14 indexed citations

Hedrick, Michael P., Kevin J. Frankowski, David A. Whipple, et al.. (2010). Selective KOP Receptor Antagonists: Probe 1.

Parrish, Jay P., David B. Kastrinsky, Frédéric Stauffer, et al.. (2003). Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065. Bioorganic & Medicinal Chemistry. 11(17). 3815–3838. 30 indexed citations

10.

Soenen, D. R., Inkyu Hwang, Michael P. Hedrick, & Dale L. Boger. (2003). Multidrug resistance reversal activity of key ningalin analogues. Bioorganic & Medicinal Chemistry Letters. 13(10). 1777–1781. 44 indexed citations

11.

Marsilje, Thomas H., Michael P. Hedrick, Joel Desharnais, et al.. (2003). 10-(2-Benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid. Bioorganic & Medicinal Chemistry. 11(20). 4503–4509. 5 indexed citations

12.

Marsilje, Thomas H., Marc Labroli, Michael P. Hedrick, et al.. (2002). 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-Formyl-DDACTHF). Bioorganic & Medicinal Chemistry. 10(8). 2739–2749. 13 indexed citations

13.

Boger, Dale L., Frédéric Stauffer, & Michael P. Hedrick. (2001). Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065. Bioorganic & Medicinal Chemistry Letters. 11(15). 2021–2024. 13 indexed citations

14.

Boger, Dale L., Hiroshi Miyauchi, & Michael P. Hedrick. (2001). α-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and α-substitution. Bioorganic & Medicinal Chemistry Letters. 11(12). 1517–1520. 79 indexed citations

15.

Boger, Dale L., Marc Labroli, Thomas H. Marsilje, et al.. (2000). Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase. Bioorganic & Medicinal Chemistry. 8(5). 1075–1086. 15 indexed citations

16.

Boger, Dale L., Michael A. Dechantsreiter, Takahiro Ishii, Brian E. Fink, & Michael P. Hedrick. (2000). Assessment of solution-phase positional scanning libraries based on distamycin A for the discovery of new DNA binding agents. Bioorganic & Medicinal Chemistry. 8(8). 2049–2057. 25 indexed citations

17.

Boger, Dale L., Thomas H. Marsilje, Michael P. Hedrick, et al.. (2000). Design, synthesis, and biological evaluation of fluoronitrophenyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase. Bioorganic & Medicinal Chemistry Letters. 10(13). 1471–1475. 9 indexed citations

18.

Boger, Dale L., Brian E. Fink, & Michael P. Hedrick. (2000). A new class of highly cytotoxic diketopiperazines. Bioorganic & Medicinal Chemistry Letters. 10(10). 1019–1020. 17 indexed citations

19.

Boger, Dale L., Alejandro Santillán, Mark Searcey, et al.. (2000). Synthesis and Evaluation of 1,2,8,8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the Parent Alkylation Subunit of CC-1065 and the Duocarmycins: Impact of the Alkylation Subunit Substituents and Its Implications for DNA Alkylation Catalysis. The Journal of Organic Chemistry. 65(13). 4101–4111. 27 indexed citations

20.

Boger, Dale L., Brian E. Fink, & Michael P. Hedrick. (2000). Total Synthesis of Distamycin A and 2640 Analogues: A Solution-Phase Combinatorial Approach to the Discovery of New, Bioactive DNA Binding Agents and Development of a Rapid, High-Throughput Screen for Determining Relative DNA Binding Affinity or DNA Binding Sequence Selectivity. Journal of the American Chemical Society. 122(27). 6382–6394. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact